Citation: El. Lecluyse et Sc. Sutton, IN-VITRO MODELS FOR SELECTION OF DEVELOPMENT CANDIDATES - PERMEABILITY STUDIES TO DEFINE MECHANISMS OF ABSORPTION ENHANCEMENT, Advanced drug delivery reviews, 23(1-3), 1997, pp. 163-183
Authors:
SUTTON SC
EVANS LAF
RINALDI MTS
NORTON KA
Citation: Sc. Sutton et al., PREDICTING INJECTION SITE MUSCLE DAMAGE .1. EVALUATION OF IMMEDIATE-RELEASE PARENTERAL FORMULATIONS IN ANIMAL-MODELS, Pharmaceutical research, 13(10), 1996, pp. 1507-1513
Authors:
SUTTON SC
EVANS LAF
RINALDI MTS
NORTON KA
Citation: Sc. Sutton et al., PREDICTING INJECTION SITE MUSCLE DAMAGE .2. EVALUATION OF EXTENDED-RELEASE PARENTERAL FORMULATIONS IN ANIMAL-MODELS, Pharmaceutical research, 13(10), 1996, pp. 1514-1518
Citation: Laf. Evans et al., PREDICTING INJECTION SITE MUSCLE DAMAGE .3. EVALUATION OF INTRAMUSCULAR FORMULATIONS IN THE L6 CELL MODEL, Pharmaceutical research, 13(10), 1996, pp. 1585-1587
Citation: Sk. Kim et al., CEPHALOSTATIN CHEMISTRY .5. CHROMIUM[II]-MEDIATED REDUCTIVE CLEAVAGE OF A TERTIARY HALIDE BEARING 3 BETA-ALKOXY GROUPS - SYNTHESIS OF THE NORTH HEXACYCLIC STEROID UNIT OF THE CEPHALOSTATIN FAMILY, Tetrahedron letters, 36(14), 1995, pp. 2427-2430
Citation: Ju. Jeong et al., CEPHALOSTATIN SYNTHESIS .9. BIOMIMETIC TOTAL SYNTHESES OF (-CEPHALOSTATIN-7, (+)-CEPHALOSTATIN-12, AND (+)-RITTERAZINE-K()), Journal of the American Chemical Society, 117(40), 1995, pp. 10157-10158
Citation: Do. Scott et al., URINARY AND BILIARY DISPOSITION OF THE LACTONE AND CARBOXYLATE FORMS OF 20(S)-CAMPTOTHECIN IN RATS, Drug metabolism and disposition, 22(3), 1994, pp. 438-442
Citation: Sc. Sutton et al., INTRANASAL DELIVERY OF THE BISPHOSPHONATE ALENDRONATE IN THE RAT AND DOG, Pharmaceutical research, 10(6), 1993, pp. 924-926
Authors:
CHENG HY
SUTTON SC
PIPKIN JD
ZENTNER GM
ROGERS JD
SCHWARTZ JI
MITCHEL YB
GRASING K
SCHWARTZ MS
AMIN RD
LIU L
EBEL DL
COULTER A
ENGLE K
MCCLELLAND GA
LUI CY
RORK GS
Citation: Hy. Cheng et al., EVALUATION OF SUSTAINED CONTROLLED-RELEASE DOSAGE FORMS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A (HMG-COA) REDUCTASE INHIBITORS IN DOGS ANDHUMANS, Pharmaceutical research, 10(11), 1993, pp. 1683-1687
Authors:
SUTTON SC
LECLUYSE EL
ENGLE K
PIPKIN JD
FIX JA
Citation: Sc. Sutton et al., ENHANCED BIOAVAILABILITY OF CEFOXITIN USING PALMITOYLCARNITINE .2. USE OF DIRECTLY COMPRESSED TABLET FORMULATIONS IN THE RAT AND DOG, Pharmaceutical research, 10(10), 1993, pp. 1516-1520
Citation: Mh. Nantz et al., A DISULFONE-BASED APPROACH TO ANSA-TITANOCENES - SYNTHESIS OF (ETHYLENEBIS(2-INDENYL))TITANIUM DICHLORIDE, Organometallics, 12(12), 1993, pp. 5012-5015
Citation: El. Lecluyse et al., INVITRO EFFECTS OF LONG-CHAIN ACYLCARNITINES ON THE PERMEABILITY, TRANSEPITHELIAL ELECTRICAL-RESISTANCE AND MORPHOLOGY OF RAT COLONIC MUCOSA, The Journal of pharmacology and experimental therapeutics, 265(2), 1993, pp. 955-962